Everything you need to know About Taxotere Lawsuits

If you have been diagnosed with a cancer or know someone who has been diagnosed with cancer, chances are you have heard of the drug Taxotere.

The drug which is manufactured and marketed by the company Sanofi-Aventis was first approved by the FDA in 1996.

Sanofi-Aventis is a major pharmaceutical company based out of France that does business all over the world.

The drug that they manufacture, Taxotere, is a popular drug used in chemotherapy across the United States. Specifically, it is utilized in the majority of breast cancer treatments, as well as other forms of cancer.

Taxotere is administered intravenously and is meant to slow the cancer cell growth in patients.

When the Taxotere first became available, it was the go to treatment for women with breast cancer. If you are looking for Taxotere lawyer, you can browse the web and can find the best lawyer.

Approximately 75% of breast cancer patients were prescribed Taxotere to fight the growth of the cancer.

Chemotherapy is never a fun thing for anyone, but Taxotere made chemotherapy even harder on hundreds of thousands of women.

 

As you also may be aware of, chemotherapy and Taxotere are accompanied by some pretty detrimental side effects.

Some common side effects include your typical nausea, vomiting, fatigue, pain, etc. Also, one of the most common side effects that are associated with chemotherapy is hair loss.

Many chemotherapy patients will experience some sort of hair loss while being administered Taxotere.

Though we know this is common in chemotherapy, Taxotere is associated with the permanent loss of hair without the ability to grow back post-chemotherapy.

Usually in chemotherapy hair loss is not permanent, but rather temporary during the chemo and radiation treatment.

However, many patients using Taxotere experienced permanent hair loss after being administered the drug.

This permanent hair loss is a very serious and unexpected result of the drug Taxotere. The condition of permanent hair loss as a result of Taxotere is referred to “alopecia.” Alopecia can have a severely adverse impact on the morale of the patient, as well as the patient’s families.